Elevated CpG island methylation of GCK gene predicts the risk of type 2 diabetes in Chinese males

Gene

Volumn 547, Issue 2, 2014, Pages 329-333

  Tang, Linlin ^a   Ye, Huadan ^a   Hong, Qingxiao ^a   Wang, Lingyan ^b   Wang, Qinwen ^a   Wang, Hongwei ^c   Xu, Leiting ^a   Bu, Shizhong ^a   Zhang, Lina ^a   Cheng, Jia ^a   Liu, Panpan ^a   Le, Yanping ^a   Ye, Meng ^a   Mai, Yifeng ^a   Duan, Shiwei ^a  

^a NINGBO UNIVERSITY   (China)

^b NINGBO NO 2 HOSPITAL   (China)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

CpG island; DNA methylation; GCK; Gender; Type 2 diabetes

Indexed keywords

CHOLESTEROL; HEXOKINASE; HEXOKINASE 4; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHINESE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CPG ISLAND; CPG4 ISLAND; DNA METHYLATION; FEMALE; GCK GENE; GENE; GENETIC RISK; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTIVE VALUE; PRIORITY JOURNAL; PYROSEQUENCING; RISK FACTOR; SEX DIFFERENCE;

CPG ISLAND; DNA METHYLATION; GCK; GENDER; TYPE 2 DIABETES;

AGED; CASE-CONTROL STUDIES; CHINA; CPG ISLANDS; DIABETES MELLITUS, TYPE 2; DNA METHYLATION; FEMALE; HEXOKINASE; HUMANS; MALE; MIDDLE AGED; PROTEIN-SERINE-THREONINE KINASES; SEX FACTORS;

EID: 84907249245     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2014.06.062     Document Type: Article

References (51)

1. Bell C.G., Finer S., Lindgren C.M., Wilson G.A., Rakyan V.K., Teschendorff A.E., Akan P., Stupka E., Down T.A., Prokopenko I., et al. Integrated genetic and epigenetic analysis identifies haplotype-specific methylation in the FTO type 2 diabetes and obesity susceptibility locus. PLoS One 2010, 5(11):e14040.
2. Bogdarina I., Murphy H.C., Burns S.P., Clark A.J. Investigation of the role of epigenetic modification of the rat glucokinase gene in fetal programming. Life Sci. 2004, 74(11):1407-1415.
3. Cappelli A., Silvestri S., Tumini S., Carinci S., Cipriano P., Massi L., Staffolani P., Pianese L. A new de novo mutation in the GCK gene causing MODY2. Diabetes Res. Clin. Pract. 2011, 93(1):e41-e43.
4. Chiha M., Njeim M., Chedrawy E.G. Diabetes and coronary heart disease: a risk factor for the global epidemic. Int. J. Hypertens. 2012, 2012:697240.
5. Dang M.N., Buzzetti R., Pozzilli P. Epigenetics in autoimmune diseases with focus on type 1 diabetes. Diabetes Metab. Res. Rev. 2013, 29(1):8-18.
6. Fendler W., Borowiec M., Antosik K., Szadkowska A., Deja G., Jarosz-Chobot P., Mysliwiec M., Wyka K., Pietrzak I., Skupien J., et al. HDL cholesterol as a diagnostic tool for clinical differentiation of GCK-MODY from HNF1A-MODY and type 1 diabetes in children and young adults. Clin. Endocrinol. (Oxf.) 2011, 75(3):321-327.
7. Fenichel P., Chevalier N., Brucker-Davis F. Bisphenol A: an endocrine and metabolic disruptor. Ann. Endocrinol. (Paris) 2013, 74(3):211-220.
8. Fradin D., Le Fur S., Mille C., Naoui N., Groves C., Zelenika D., McCarthy M.I., Lathrop M., Bougneres P. Association of the CpG methylation pattern of the proximal insulin gene promoter with type 1 diabetes. PLoS One 2012, 7(5):e36278.
9. Gaikwad A.B., Sayyed S.G., Lichtnekert J., Tikoo K., Anders H.J. Renal failure increases cardiac histone h3 acetylation, dimethylation, and phosphorylation and the induction of cardiomyopathy-related genes in type 2 diabetes. Am. J. Pathol. 2010, 176(3):1079-1083.
10. Gillberg L., Jacobsen S., Ribel-Madsen R., Gjesing A.P., Boesgaard T.W., Ling C., Pedersen O., Hansen T., Vaag A. Does DNA methylation of PPARGC1A influence insulin action in first degree relatives of patients with type 2 diabetes?. PLoS One 2013, 8(3):e58384.
11. Guo J.A., Mo P.S., Li G.X. Immobilization of glucose oxidase and peroxidase and their application in flow-injection analysis for glucose in serum. Appl. Biochem. Biotechnol. 1990, 23(1):15-24.
12. Hamamdzic D., Fenning R.S., Patel D., Mohler E.R., Orlova K.A., Wright A.C., Llano R., Keane M.G., Shannon R.P., Birnbaum M.J., et al. Akt pathway is hypoactivated by synergistic actions of diabetes mellitus and hypercholesterolemia resulting in advanced coronary artery disease. Am. J. Physiol. Heart Circ. Physiol. 2010, 299(3):H699-H706.
13. Herder C., Roden M. Genetics of type 2 diabetes: pathophysiologic and clinical relevance. Eur. J. Clin. Invest. 2011, 41(6):679-692.
14. Huxley R., Barzi F., Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 2006, 332(7533):73-78.
15. Inder W.J., Obeyesekere V.R., Jang C., Saffery R. Evidence for transcript-specific epigenetic regulation of glucocorticoid-stimulated skeletal muscle 11beta-hydroxysteroid dehydrogenase-1 activity in type 2 diabetes. Clin. Epigenet. 2012, 4(1):24.
16. Iynedjian P.B. Mammalian glucokinase and its gene. Biochem. J. 1993, 293(Pt 1):1-13.
17. Jiang M.H., Fei J., Lan M.S., Lu Z.P., Liu M., Fan W.W., Gao X., Lu D.R. Hypermethylation of hepatic Gck promoter in ageing rats contributes to diabetogenic potential. Diabetologia 2008, 51(8):1525-1533.
18. Jiang M., Zhang Y., Liu M., Lan M.S., Fei J., Fan W., Gao X., Lu D. Hypermethylation of hepatic glucokinase and L-type pyruvate kinase promoters in high-fat diet-induced obese rats. Endocrinology 2011, 152(4):1284-1289.
19. K.P., Kunikullaya U.K., Goturu J. Glycosylated haemoglobin (HbA1c) - a marker of circulating lipids in type 2 diabetic patients. J. Clin. Diagn. Res. 2014, 8:20-23.
20. Kamenov Z.A., Parapunova R.A., Georgieva R.T. Earlier development of diabetic neuropathy in men than in women with type 2 diabetes mellitus. Gend. Med. 2010, 7(6):600-615.
21. Kaminsky Z., Wang S.C., Petronis A. Complex disease, gender and epigenetics. Ann. Med. 2006, 38(8):530-544.
22. Kirchner H., Osler M.E., Krook A., Zierath J.R. Epigenetic flexibility in metabolic regulation: disease cause and prevention?. Trends Cell Biol. 2013, 23(5):203-209.
23. Krupanidhi S., Sedimbi S.K., Vaishnav G., Madhukar S.S., Sanjeevi C.B. Diabetes-role of epigenetics, genetics, and physiological factors. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2009, 34(9):837-845.
24. Labayen I., Ruiz J.R., Huybrechts I., Ortega F.B., Rodriguez G., Dehenauw S., Breidenassel C., Jimenez-Pavon D., Vyncke K.E., Censi L., et al. Sexual dimorphism in the early life programming of serum leptin levels in European adolescents: the HELENA study. J. Clin. Endocrinol. Metab. 2011, 96(8):E1330-E1334.
25. Laughlin G.A., Barrett-Connor E., Cummins K.M., Daniels L.B., Wassel C.L., Ix J.H. Sex-specific association of fetuin-A with type 2 diabetes in older community-dwelling adults: the Rancho Bernardo study. Diabetes Care 2013, 36(7):1994-2000.
26. Lee I.T., Wang C.Y., Huang C.N., Fu C.C., Sheu W.H. High triglyceride-to-HDL cholesterol ratio associated with albuminuria in type 2 diabetic subjects. J. Diabetes Complications 2013, 27(3):243-247.
27. Liu Z.H., Chen L.L., Deng X.L., Song H.J., Liao Y.F., Zeng T.S., Zheng J., Li H.Q. Methylation status of CpG sites in the MCP-1 promoter is correlated to serum MCP-1 in type 2 diabetes. J. Endocrinol. Invest. 2012, 35(6):585-589.
28. Lopes-Virella M.F., Stone P., Ellis S., Colwell J.A. Cholesterol determination in high-density lipoproteins separated by three different methods. Clin. Chem. 1977, 23(5):882-884.
29. Ma Y., Xia W., Wang D.Q., Wan Y.J., Xu B., Chen X., Li Y.Y., Xu S.Q. Hepatic DNA methylation modifications in early development of rats resulting from perinatal BPA exposure contribute to insulin resistance in adulthood. Diabetologia 2013, 56(9):2059-2067.
30. Machann J., Thamer C., Schnoedt B., Stefan N., Stumvoll M., Haring H.U., Claussen C.D., Fritsche A., Schick F. Age and gender related effects on adipose tissue compartments of subjects with increased risk for type 2 diabetes: a whole body MRI/MRS study. MAGMA 2005, 18(3):128-137.
31. Maier S., Olek A. Diabetes: a candidate disease for efficient DNA methylation profiling. J. Nutr. 2002, 132(8 Suppl.):2440S-2443S.
32. McCombe P.A., Greer J.M., Mackay I.R. Sexual dimorphism in autoimmune disease. Curr. Mol. Med. 2009, 9(9):1058-1079.
33. Monami M., Vitale V., Ambrosio M.L., Bartoli N., Toffanello G., Ragghianti B., Monami F., Marchionni N., Mannucci E. Effects on lipid profile of dipeptidyl peptidase 4 inhibitors, pioglitazone, acarbose, and sulfonylureas: meta-analysis of placebo-controlled trials. Adv. Ther. 2012, 29(9):736-746.
34. Morgantini C., Meriwether D., Baldi S., Venturi E., Pinnola S., Wagner A.C., Fogelman A.M., Ferrannini E., Natali A., Reddy S.T. HDL lipid composition is profoundly altered in patients with type 2 diabetes and atherosclerotic vascular disease. Nutr. Metab. Cardiovasc. Dis. 2014, 24(6):594-599.
35. Nitert M.D., Dayeh T., Volkov P., Elgzyri T., Hall E., Nilsson E., Yang B.T., Lang S., Parikh H., Wessman Y., et al. Impact of an exercise intervention on DNA methylation in skeletal muscle from first-degree relatives of patients with type 2 diabetes. Diabetes 2012, 61(12):3322-3332.
36. Paolillo S., Della Ratta G.L., Vitagliano A., Cirillo A., Lardino E., Formisano T., Fabiani I., Pellegrino A.M., Riello P., Filardi P.P. New perspectives in cardiovascular risk reduction: focus on HDL. Monaldi Arch. Chest Dis. 2013, 80:27-30.
37. Pradeepa R., Anitha B., Mohan V., Ganesan A., Rema M. Risk factors for diabetic retinopathy in a South Indian type 2 diabetic population-the Chennai Urban Rural Epidemiology Study (CURES) Eye Study 4. Diabet. Med. 2008, 25(5):536-542.
38. Printz R.L., Magnuson M.A., Granner D.K. Mammalian glucokinase. Annu. Rev. Nutr. 1993, 13:463-496.
39. Ribel-Madsen R., Fraga M.F., Jacobsen S., Bork-Jensen J., Lara E., Calvanese V., Fernandez A.F., Friedrichsen M., Vind B.F., Hojlund K., et al. Genome-wide analysis of DNA methylation differences in muscle and fat from monozygotic twins discordant for type 2 diabetes. PLoS One 2012, 7(12):e51302.
40. Ripsin C.M., Kang H., Urban R.J. Management of blood glucose in type 2 diabetes mellitus. Am. Fam. Physician 2009, 79(1):29-36.
41. Riserus U., Willett W.C., Hu F.B. Dietary fats and prevention of type 2 diabetes. Prog. Lipid Res. 2009, 48(1):44-51.
42. Sanchez-Quesada J.L., Vinagre I., De Juan-Franco E., Sanchez-Hernandez J., Bonet-Marques R., Blanco-Vaca F., Ordonez-Llanos J., Perez A. Impact of the LDL subfraction phenotype on Lp-PLA2 distribution, LDL modification and HDL composition in type 2 diabetes. Cardiovasc. Diabetol. 2013, 12:112.
43. Sayyed S.G., Gaikwad A.B., Lichtnekert J., Kulkarni O., Eulberg D., Klussmann S., Tikoo K., Anders H.J. Progressive glomerulosclerosis in type 2 diabetes is associated with renal histone H3K9 and H3K23 acetylation, H3K4 dimethylation and phosphorylation at serine 10. Nephrol. Dial. Transplant. 2010, 25(6):1811-1817.
44. Schumann G., Klauke R., Canalias F., Bossert-Reuther S., Franck P.F., Gella F.J., Jorgensen P.J., Kang D., Lessinger J.M., Panteghini M., et al. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C. Part 9: reference procedure for the measurement of catalytic concentration of alkaline phosphatase International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Scientific Division, Committee on Reference Systems of Enzymes (C-RSE) (1). Clin. Chem. Lab. Med. 2011, 49(9):1439-1446.
45. Williams textbook of endocrinology 2011, 1371-1435. Elsevier/Saunders, Philadelphia. (12th ed.).
46. World Health Organization Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation 2006, 21. Geneva, Switzerland.
47. Xu L., Zheng D., Wang L., Jiang D., Liu H., Xu L., Liao Q., Zhang L., Liu P., Shi X., Wang Z., Sun L., Zhou Q., Li N., Huang Y., Le Y., Ye M., Shao G., Duan S. GCK gene-body hypomethylation is associated with the risk of coronary heart disease. Biomed. Res. Int. 2014, 151723.
48. Yang M., Sun J.Z., Sun Y.L., You W., Dai J., Li G.S. Association between leptin gene promoter methylation and type 2 diabetes mellitus. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2012, 29(4):474-477.
49. Yang B.T., Dayeh T.A., Volkov P.A., Kirkpatrick C.L., Malmgren S., Jing X., Renstrom E., Wollheim C.B., Nitert M.D., Ling C. Increased DNA methylation and decreased expression of PDX-1 in pancreatic islets from patients with type 2 diabetes. Mol. Endocrinol. 2012, 26(7):1203-1212.
50. Yu J., He L.Y., Han J.L., Li Z.P., Feng X.H., Gao W. Correlation of low density lipoprotein cholesterol with coronary flow reserve in patients with type 2 diabetes. Beijing Da Xue Xue Bao 2014, 46(1):155-159.
51. Zeng X.N., Yin R.X., Huang P., Huang K.K., Wu J., Guo T., Lin Q.Z., Aung L.H., Wu J.Z., Wang Y.M. Association of the MLXIPL/TBL2 rs17145738 SNP and serum lipid levels in the Guangxi Mulao and Han populations. Lipids Health Dis. 2013, 12:156.